n(g),n(g')-dimethyl-l-arginine has been researched along with Sclerosis, Systemic in 11 studies
N,N-dimethylarginine: asymmetric dimethylarginine; do not confuse with N,N'-dimethylarginine
| Excerpt | Relevance | Reference |
|---|---|---|
| " The aim of this study was to examine associations between asymmetric dimethylarginine (ADMA) - a biomarker of atherosclerosis - and assessments of macrovascular endothelial function in patients with SSc." | 4.31 | The role of asymmetric dimethylarginine in endothelial dysfunction and abnormal nitric oxide metabolism in systemic sclerosis: results from a pilot study. ( Dimitroulas, T; Doumas, M; Garyfallos, A; Karagiannis, A; Katsiki, N; Kitas, G; Loutradis, C; Malliari, A; Pagkopoulou, E; Soulaidopoulos, S, 2023) |
| " While there is no established dosing regimen, studies of oral l-arginine in secondary RP suggest that divided dosing may begin at 1-2 g/day and may be titrated up to 10 g/day." | 2.61 | The clinical effects of l-arginine and asymmetric dimethylarginine: implications for treatment in secondary Raynaud's phenomenon. ( Curtiss, P; Franks, AG; Lo Sicco, K; Schwager, Z, 2019) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (9.09) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (27.27) | 29.6817 |
| 2010's | 5 (45.45) | 24.3611 |
| 2020's | 2 (18.18) | 2.80 |
| Authors | Studies |
|---|---|
| Pagkopoulou, E | 2 |
| Soulaidopoulos, S | 2 |
| Triantafyllidou, E | 1 |
| Loutradis, C | 2 |
| Malliari, A | 2 |
| Kitas, GD | 1 |
| Garyfallos, A | 3 |
| Dimitroulas, T | 4 |
| Katsiki, N | 1 |
| Karagiannis, A | 1 |
| Doumas, M | 1 |
| Kitas, G | 1 |
| Curtiss, P | 1 |
| Schwager, Z | 1 |
| Lo Sicco, K | 1 |
| Franks, AG | 1 |
| Ciurzyński, M | 1 |
| Bienias, P | 1 |
| Irzyk, K | 1 |
| Kostrubiec, M | 1 |
| Bartoszewicz, Z | 1 |
| Siwicka, M | 1 |
| Stelmaszczyk-Emmel, A | 1 |
| Górska, E | 1 |
| Demkow, U | 1 |
| Pruszczyk, P | 1 |
| Zhang, L | 1 |
| Wan, YN | 1 |
| Zhao, JH | 1 |
| Wang, YJ | 1 |
| Wang, YX | 1 |
| Yan, JW | 1 |
| Huang, XL | 1 |
| Wang, J | 1 |
| Blaise, S | 1 |
| Maas, R | 1 |
| Trocme, C | 1 |
| Kom, GD | 1 |
| Roustit, M | 1 |
| Carpentier, PH | 1 |
| Cracowski, JL | 1 |
| Giannakoulas, G | 2 |
| Papadopoulou, K | 2 |
| Karvounis, H | 2 |
| Dimitroula, H | 2 |
| Koliakos, G | 2 |
| Karamitsos, T | 1 |
| Parcharidou, D | 2 |
| Settas, L | 2 |
| Sfetsios, T | 1 |
| Styliadis, I | 1 |
| Dooley, A | 1 |
| Gao, B | 1 |
| Bradley, N | 1 |
| Abraham, DJ | 1 |
| Black, CM | 1 |
| Jacobs, M | 1 |
| Bruckdorfer, KR | 1 |
| Wipff, J | 1 |
| Avouac, J | 1 |
| Borderie, D | 1 |
| Zerkak, D | 1 |
| Lemarechal, H | 1 |
| Kahan, A | 1 |
| Boileau, C | 1 |
| Allanore, Y | 1 |
| Lischwe, MA | 1 |
| Ochs, RL | 1 |
| Reddy, R | 1 |
| Cook, RG | 1 |
| Yeoman, LC | 1 |
| Tan, EM | 1 |
| Reichlin, M | 1 |
| Busch, H | 1 |
2 reviews available for n(g),n(g')-dimethyl-l-arginine and Sclerosis, Systemic
| Article | Year |
|---|---|
The clinical effects of l-arginine and asymmetric dimethylarginine: implications for treatment in secondary Raynaud's phenomenon.
Topics: Arginine; Humans; Nitric Oxide; Nitric Oxide Synthase Type III; Raynaud Disease; Scleroderma, System | 2019 |
The association between systemic sclerosis, arginine and asymmetric dimethylarginine.
Topics: Animals; Arginine; Case-Control Studies; Humans; Nitric Oxide; Scleroderma, Systemic | 2015 |
9 other studies available for n(g),n(g')-dimethyl-l-arginine and Sclerosis, Systemic
| Article | Year |
|---|---|
Asymmetric dimethylarginine correlates with worsening peripheral microangiopathy in systemic sclerosis.
Topics: Adult; Aged; Capillaries; Cross-Sectional Studies; Female; Humans; Male; Microcirculation; Microscop | 2023 |
The role of asymmetric dimethylarginine in endothelial dysfunction and abnormal nitric oxide metabolism in systemic sclerosis: results from a pilot study.
Topics: Adult; Aged; Arginine; Atherosclerosis; Biomarkers; Carotid Intima-Media Thickness; Cross-Sectional | 2023 |
Serum endothelin-1 and NT-proBNP, but not ADMA, endoglin and TIMP-1 levels, reflect impaired right ventricular function in patients with systemic sclerosis.
Topics: Adult; Aged; Antigens, CD; Arginine; Biomarkers; Case-Control Studies; Collagen; Echocardiography; E | 2014 |
Correlation of biomarkers of endothelium dysfunction and matrix remodeling in patients with systemic sclerosis.
Topics: Arginine; Biomarkers; Endothelium, Vascular; Enzyme Inhibitors; Extracellular Matrix; Female; Humans | 2009 |
Early detection of cardiac involvement in systemic sclerosis assessed by tissue-Doppler echocardiography: relationship with neurohormonal activation and endothelial dysfunction.
Topics: Adult; Aged; Analysis of Variance; Arginine; Blood Flow Velocity; Echocardiography, Doppler; Endothe | 2010 |
Left atrial volume and N-terminal pro-B type natriuretic peptide are associated with elevated pulmonary artery pressure in patients with systemic sclerosis.
Topics: Aged; Arginine; Biomarkers; Blood Pressure; Cross-Sectional Studies; Female; Follow-Up Studies; Hear | 2010 |
Abnormal nitric oxide metabolism in systemic sclerosis: increased levels of nitrated proteins and asymmetric dimethylarginine.
Topics: Adult; Arginine; Cells, Cultured; Endothelium, Vascular; Enzyme Inhibitors; Female; Humans; Male; Mi | 2006 |
Disturbed angiogenesis in systemic sclerosis: high levels of soluble endoglin.
Topics: Adult; Aged; Antigens, CD; Arginine; Biomarkers; Cross-Sectional Studies; Endoglin; Female; Humans; | 2008 |
Purification and partial characterization of a nucleolar scleroderma antigen (Mr = 34,000; pI, 8.5) rich in NG,NG-dimethylarginine.
Topics: Amino Acid Sequence; Amino Acids; Animals; Antigens; Arginine; Autoantibodies; Cell Nucleolus; Fluor | 1985 |